USFDA concludes inspection at Zydus’ LiqMeds in U.K. with four observations
LiqMeds Group was acquired by Zydus Lifesciences via its subsidiary Zydus Pharmaceuticals U.K. in October 2023. File. Zydus Lifesciences on Saturday (November 14, 2026) said the U.S. health regulator has concluded its inspection at LiqMeds, U.K., with four observations. The inspection was conducted from November 9-13, the company said in a regulatory filing to stock…
Read More “USFDA concludes inspection at Zydus’ LiqMeds in U.K. with four observations” »